To Update from Neuro Kinetics, Inc. We're sending you this e-newsletter because we have a business relationship with you. Please see below if you do not want to receive marketing materials from us. We hope you'll let us stay in touch with you, and that you'll help us grow by forwarding this e-mail to colleagues who have an interest in neurological, neuro-otological, vestibular and ophthalmic issues.
THE POWER OF THE PRESS: NEURO KINETICS & MISLEADING NEWSPAPER ARTICLE
At Neuro Kinetics, we know all about “the power of the press.” A recent newspaper report might have left readers with the wrong impression about our interaction with the U.S. Food & Drug Administration. We asked the newspaper for a correction and it published one (read it here). We also distributed a statement from our CEO, Howison Schroeder (read here). Our concern was that someone using a Web search engine to research us might see the newspaper article and we wanted to get the correct facts out in cyberspace too. And with the correction and the statement, we thought the matter was closed. Wrong. The CEO of a competitor distributed an e-mail reiterating the false information. So we took another step and sent an e-mail, again from Schroeder, to set the record straight (read here). Now, we hope, this matter really is behind us and we can all get back to work.
CARING FOR AMERICA'S RETURNING SOLDIERS: RESEARCH AND DETECTION OF BRAIN INJURIES
With an estimated 20% of soldiers returning from Afghanistan and Iraq suffering from mild traumatic brain injuries (mTBI), we’re working with the U.S. Army Aeromedical Research Laboratory and other military medical facilities to improve diagnosis and treatment of combat blast victims. The project focuses on neuro-otologic testing using the battery of tests incorporated in our I-Portal® NOTC system. Research suggests that the oculometric measurements included in the I-Portal® NOTC’s battery of tests can provide effective neuro-physiologic and vestibular-auditory evaluations for mTBI, and that in turn can improve early screening and treatment. Read our news release here.
VEST 6.8 ON ITS WAY: UPGRADES & ENHANCEMENTS TO CONTROL & ANALYSIS SOFTWARE
A few weeks ago, at the American Academy of Otolaryngology (AAO) conference in San Diego, we previewed the soon-to-be released version 6.8 of our VEST™ control and analysis software. VEST™, of course, is central to our users’ ability to utilize our equipment to perform and analyze tests that are accurate, reliable and efficient. The upgraded software, which we expect to ship early in the new year, will give clinicians the ability to better serve their patients through enhanced testing (including improvements to the Dynamic Unilateral Centrifugation Test and various nystagmus tests) and greater ease of use of our equipment. Read more here.
PATENT ISSUED FOR "REGION OF INTEREST CONTROL" FEATURE
As a leading innovator in the field of eye-tracking and neuro-otologic diagnostic systems, we’re proud of the intellectual property we’ve developed. We currently have four issued patents and close to a dozen new ones pending. One recently issued patent protects our exclusive “region of interest control,” a digital zoom feature that gives users of our I-Portal® product line the ability to crop images and increase video frame rates. That’s important because it enhances temporal resolution without sacrificing image quality, enabling clinicians to observe phenomena that otherwise could not be seen at slower frame rates or with poor quality images. Read the full patent filing here.
PROFILE: MEET ALEX KIDERMAN, CHIEF TECHNOLOGY OFFICER
One of our top priorities these days is to expand the clinical utility of our testing devices and give more practitioners around the world the ability to generate – quickly and in their own offices -- a wider range of data and analysis. It’s an ambitious goal. At the forefront of the push is Dr. Alex Kiderman, our chief technology officer. Kiderman, a native of Russia, brings decades of experience as an engineer active in the mining, filtration and medical device industries. He is both a creative visionary and a pragmatic nuts-and-bolts problem solver. Read his profile here.
VESTIBULAR TESTING: THE FUTURE IS IN THE BALANCE
As the population ages, the number of balanced-troubled patients seeking treatment from audiologists is bound to increase. But will those specialists be sufficiently proficient in advanced vestibular testing and assessments to meet the challenge? That’s a question posed by Christopher Zalewski, MA, a researcher at The National Institutes of Health in a Neuro Kinetics-sponsored column published in the professional publication ADVANCE For Audiologists. Argues Zalewski, “it is imperative that we broaden our expertise and embrace an assessment beyond the traditional ENG/VNG.” Read his full opinion piece here.
And to all of you, from all of us at Neuro Kinetics, the best of the holiday season!
For information about any Neuro Kinetics product or service, please call Mark Burchfield at 412-963-6649.
Got a comment about Update? Please send it to firstname.lastname@example.org.
Rights to products and services noted in this newsletter and linked Neuro Kinetics, Inc. pages are registered trademarks of Neuro Kinetics, Inc.
© 2009 Neuro Kinetics, Inc.